17,090 Shares in Everus (NYSE:ECG) Purchased by Moors & Cabot Inc.

Moors & Cabot Inc. purchased a new position in shares of Everus (NYSE:ECGFree Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 17,090 shares of the company’s stock, valued at approximately $1,124,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ECG. Forza Wealth Management LLC acquired a new position in Everus during the 4th quarter worth about $336,000. Mendota Financial Group LLC acquired a new position in Everus during the 4th quarter valued at about $36,000. SeaCrest Wealth Management LLC acquired a new position in Everus during the 4th quarter valued at about $292,000. Hennessy Advisors Inc. acquired a new position in Everus during the 4th quarter valued at about $31,611,000. Finally, Brady Martz Wealth Solutions LLC acquired a new position in Everus during the 4th quarter valued at about $472,000.

Insider Activity

In other Everus news, Director Edward A. Ryan bought 1,400 shares of the stock in a transaction that occurred on Tuesday, February 25th. The stock was acquired at an average cost of $38.02 per share, with a total value of $53,228.00. Following the purchase, the director now owns 14,928 shares in the company, valued at $567,562.56. This trade represents a 10.35 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Maximillian J. Marcy bought 1,300 shares of the stock in a transaction that occurred on Tuesday, February 25th. The shares were acquired at an average cost of $38.99 per share, with a total value of $50,687.00. Following the completion of the purchase, the chief financial officer now owns 5,508 shares in the company, valued at $214,756.92. This represents a 30.89 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 3,750 shares of company stock valued at $153,853 in the last ninety days.

Everus Stock Down 2.3 %

Shares of ECG stock opened at $37.84 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50. The company has a 50-day moving average of $58.41. Everus has a one year low of $37.00 and a one year high of $77.93.

Everus (NYSE:ECGGet Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The company reported $0.67 EPS for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06). As a group, research analysts expect that Everus will post 2.49 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ECG shares. Oppenheimer upped their target price on shares of Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Tuesday, January 7th. Wolfe Research started coverage on shares of Everus in a research report on Tuesday, December 3rd. They set a “peer perform” rating on the stock. Finally, Stifel Nicolaus cut their target price on shares of Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th.

Read Our Latest Report on ECG

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Recommended Stories

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.